Kane Biotech KNBIF Stock
Kane Biotech Price Chart
Kane Biotech KNBIF Financial and Trading Overview
| Kane Biotech stock price | 0.03 USD |
| Previous Close | 0.03 USD |
| Open | 0.03 USD |
| Bid | 0.02 USD x 5000000 |
| Ask | 0.02 USD x 3000000 |
| Day's Range | 0.03 - 0.03 USD |
| 52 Week Range | 0.02 - 0.04 USD |
| Volume | 20K USD |
| Avg. Volume | 6.93K USD |
| Market Cap | 5.13M USD |
| Beta (5Y Monthly) | 0.287 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
KNBIF Valuation Measures
| Enterprise Value | 6.65M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 87.5203 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 113.51 |
| Enterprise Value/EBITDA | -3.183 |
Trading Information
Kane Biotech Stock Price History
| Beta (5Y Monthly) | 0.287 |
| 52-Week Change | -28.57% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 0.04 USD |
| 52 Week Low | 0.02 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 0.03 USD |
KNBIF Share Statistics
| Avg. Volume (3 month) | 6.93K USD |
| Avg. Daily Volume (10-Days) | 2.22K USD |
| Shares Outstanding | 205.06M |
| Float | 105.14M |
| Short Ratio | N/A |
| % Held by Insiders | 39.84% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1557.91% |
| Gross Margin | -80.21% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -58.074% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 58.57K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | -89.50% |
| Gross Profit (ttm) | -46986 USD |
| EBITDA | -2089077 USD |
| Net Income Avi to Common (ttm) | -2217569 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 395.06K USD |
| Total Cash Per Share (mrq) | 0.002 USD |
| Total Debt (mrq) | 1.92M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.453 |
| Book Value Per Share (mrq) | -0.0057364 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2637384 USD |
| Levered Free Cash Flow (ttm) | -2129783 USD |
Profile of Kane Biotech
| Country | United States |
| State | MB |
| City | Winnipeg |
| Address | 290-100 Innovation Drive |
| ZIP | R3T 6G2 |
| Phone | 204-453-1301 |
| Website | https://kanebiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, a biofilm destabilizing formula with continuous activity; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine (PNAG) for treating wounds and otic infections. Its wound care product portfolio includes antimicrobial wound gel, antimicrobial wound gel spray, and antimicrobial wound rinse under revyve name, as well as antimicrobial surgical hydrogel under coactiv+ name. In addition, the company offers scalp detoxifier product line under the Omni Bioceuticals brand. Further, it engages in developing coactiv+ Antimicrobial Surgical Hydrogel for use in surgical/acute wounds; revyve Antimicrobial Wound Rinse for use in acute and chronic wounds; DispersinB Hydrogel for use in surgical/acute wounds; and DispersinB Acne Cleanser for use in the treatment of mild to moderate acne vulgaris. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.
Q&A For Kane Biotech Stock
What is a current KNBIF stock price?
Kane Biotech KNBIF stock price today per share is 0.03 USD.
How to purchase Kane Biotech stock?
You can buy KNBIF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kane Biotech?
The stock symbol or ticker of Kane Biotech is KNBIF.
Which industry does the Kane Biotech company belong to?
The Kane Biotech industry is Biotechnology.
How many shares does Kane Biotech have in circulation?
The max supply of Kane Biotech shares is 205.06M.
What is Kane Biotech Price to Earnings Ratio (PE Ratio)?
Kane Biotech PE Ratio is now.
What was Kane Biotech earnings per share over the trailing 12 months (TTM)?
Kane Biotech EPS is -0.01 USD over the trailing 12 months.
Which sector does the Kane Biotech company belong to?
The Kane Biotech sector is Healthcare.